Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines

A. Bonomi; E. Ghezzi; L. Pascucci; M. Aralla; V. Ceserani; L. Pettinari; V. Coccè; A. Guercio; G. Alessandri; E. Parati; A. T. Brini; O. Zeira; A. Pessina

doi:10.1016/j.tvjl.2017.05.005

Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines

A. Bonomi, E. Ghezzi, L. Pascucci, M. Aralla, V. Ceserani, L. Pettinari, V. Coccè, A. Guercio, G. Alessandri, E. Parati, A. T. Brini, O. Zeira, A. Pessina

Research output: Contribution to journal › Article › peer-review

Abstract

This study investigated whether canine mesenchymal stromal cells (cMSCs) are able to take up and release paclitaxel (PTX) in active form, and therefore whether they have potential as a tool for therapeutic delivery of this drug. cMSCs from bone marrow and adipose tissue were isolated, expanded and characterised phenotypically. cMSCs were loaded with PTX (cMSCs-PTX) and their capacity for release of PTX was determined by their effect on proliferation of cancer cells. cMSCs-PTX derived from bone marrow and adipose tissue were able to take up and then release active PTX. cMSCs-PTC inhibited proliferation of the canine glioma cell line J3T, and the human glioblastoma cell lines T98G and U87MG. The potential of canine cMSCs-PTX for treatment of canine gliomas should be investigated further.

Original language	English
Pages (from-to)	41-47
Number of pages	7
Journal	Veterinary Journal
Volume	223
DOIs	https://doi.org/10.1016/j.tvjl.2017.05.005
Publication status	Published - May 1 2017

Keywords

Canine
Drug delivery
Glioma
Mesenchymal stromal cells
Paclitaxel

ASJC Scopus subject areas

Animal Science and Zoology
veterinary(all)

Access to Document

10.1016/j.tvjl.2017.05.005

Cite this

Bonomi, A., Ghezzi, E., Pascucci, L., Aralla, M., Ceserani, V., Pettinari, L., Coccè, V., Guercio, A., Alessandri, G., Parati, E., Brini, A. T., Zeira, O., & Pessina, A. (2017). Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines. Veterinary Journal, 223, 41-47. https://doi.org/10.1016/j.tvjl.2017.05.005

Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines. / Bonomi, A.; Ghezzi, E.; Pascucci, L.; Aralla, M.; Ceserani, V.; Pettinari, L.; Coccè, V.; Guercio, A.; Alessandri, G.; Parati, E.; Brini, A. T.; Zeira, O.; Pessina, A.

In: Veterinary Journal, Vol. 223, 01.05.2017, p. 41-47.

Research output: Contribution to journal › Article › peer-review

Bonomi, A, Ghezzi, E, Pascucci, L, Aralla, M, Ceserani, V, Pettinari, L, Coccè, V, Guercio, A, Alessandri, G, Parati, E, Brini, AT, Zeira, O & Pessina, A 2017, 'Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines', Veterinary Journal, vol. 223, pp. 41-47. https://doi.org/10.1016/j.tvjl.2017.05.005

@article{fbfb0d480e4247258b14d8e2411121c8,

title = "Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines",

abstract = "This study investigated whether canine mesenchymal stromal cells (cMSCs) are able to take up and release paclitaxel (PTX) in active form, and therefore whether they have potential as a tool for therapeutic delivery of this drug. cMSCs from bone marrow and adipose tissue were isolated, expanded and characterised phenotypically. cMSCs were loaded with PTX (cMSCs-PTX) and their capacity for release of PTX was determined by their effect on proliferation of cancer cells. cMSCs-PTX derived from bone marrow and adipose tissue were able to take up and then release active PTX. cMSCs-PTC inhibited proliferation of the canine glioma cell line J3T, and the human glioblastoma cell lines T98G and U87MG. The potential of canine cMSCs-PTX for treatment of canine gliomas should be investigated further.",

keywords = "Canine, Drug delivery, Glioma, Mesenchymal stromal cells, Paclitaxel",

author = "A. Bonomi and E. Ghezzi and L. Pascucci and M. Aralla and V. Ceserani and L. Pettinari and V. Cocc{\`e} and A. Guercio and G. Alessandri and E. Parati and Brini, {A. T.} and O. Zeira and A. Pessina",

year = "2017",

month = may,

day = "1",

doi = "10.1016/j.tvjl.2017.05.005",

language = "English",

volume = "223",

pages = "41--47",

journal = "Veterinary Journal",

issn = "1090-0233",

publisher = "Bailliere Tindall Ltd",

}

TY - JOUR

T1 - Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines

AU - Bonomi, A.

AU - Ghezzi, E.

AU - Pascucci, L.

AU - Aralla, M.

AU - Ceserani, V.

AU - Pettinari, L.

AU - Coccè, V.

AU - Guercio, A.

AU - Alessandri, G.

AU - Parati, E.

AU - Brini, A. T.

AU - Zeira, O.

AU - Pessina, A.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - This study investigated whether canine mesenchymal stromal cells (cMSCs) are able to take up and release paclitaxel (PTX) in active form, and therefore whether they have potential as a tool for therapeutic delivery of this drug. cMSCs from bone marrow and adipose tissue were isolated, expanded and characterised phenotypically. cMSCs were loaded with PTX (cMSCs-PTX) and their capacity for release of PTX was determined by their effect on proliferation of cancer cells. cMSCs-PTX derived from bone marrow and adipose tissue were able to take up and then release active PTX. cMSCs-PTC inhibited proliferation of the canine glioma cell line J3T, and the human glioblastoma cell lines T98G and U87MG. The potential of canine cMSCs-PTX for treatment of canine gliomas should be investigated further.

AB - This study investigated whether canine mesenchymal stromal cells (cMSCs) are able to take up and release paclitaxel (PTX) in active form, and therefore whether they have potential as a tool for therapeutic delivery of this drug. cMSCs from bone marrow and adipose tissue were isolated, expanded and characterised phenotypically. cMSCs were loaded with PTX (cMSCs-PTX) and their capacity for release of PTX was determined by their effect on proliferation of cancer cells. cMSCs-PTX derived from bone marrow and adipose tissue were able to take up and then release active PTX. cMSCs-PTC inhibited proliferation of the canine glioma cell line J3T, and the human glioblastoma cell lines T98G and U87MG. The potential of canine cMSCs-PTX for treatment of canine gliomas should be investigated further.

KW - Canine

KW - Drug delivery

KW - Glioma

KW - Mesenchymal stromal cells

KW - Paclitaxel

UR - http://www.scopus.com/inward/record.url?scp=85020720634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020720634&partnerID=8YFLogxK

U2 - 10.1016/j.tvjl.2017.05.005

DO - 10.1016/j.tvjl.2017.05.005

M3 - Article

C2 - 28671070

AN - SCOPUS:85020720634

VL - 223

SP - 41

EP - 47

JO - Veterinary Journal

JF - Veterinary Journal

SN - 1090-0233

ER -

Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this